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ABSTRACT Stearic acid is toxic for T lymphocytes in vitro
but has little effect on B lymphocytes. To investigate the
molecular basis for this difference, purified murine T and B
lymphocytes were compared for their abilities to incorporate
and metabolize stearic acid. Unstimulated T and B cells
incorporated identical amounts of stearic acid into six different
phospholipids and four neutral lipids. After mitogen stimula-
tion, fatty acid uptake was increased in both lymphocyte types,
but cell-specific differences were seen in the distribution of
stearic acid among the various cellular lipids. Doses of stearic
acid that selectively inhibited T-cell proliferation resulted in a
5-fold greater accumulation of distearoylphosphatidylcholine
in T cells than in B cells. Whereas T cells did not desaturate the
exogenously derived stearic acid, up to 25% of the saturated
fatty acid was converted to oleic acid in B cells. These findings
suggested a deficiency of stearoyl-CoA desaturase (acyl-CoA,
hydrogen-donor:oxygen oxidoreductase, EC 1.14.99.5) activity
in T cells, which was confirmed by subsequent studies. Cell-free
extracts from B cells displayed nearly 20-fold more stearoyl-
CoA desaturase activity than T-cell extracts, and the level of
stearoyl-CoA desaturase mRNA was 30-fold higher in B cells.
Collectively, our data indicate that murine T cells are deficient
in unsaturated fatty acid synthesis. The deficiency of stearoyl-
CoA desaturase in T cells may represent the basis for the
differing sensitivities of T and B lymphocytes to inhibition by
saturated fatty acids.
Saturated and unsaturated fatty acids markedly affect lym-
phocyte function both in vivo and in vitro (for review, see
refs. 1-3). In general, saturated fatty acids and high levels
(>20 AuM) of unsaturated fatty acids are inhibitory, whereas
low amounts (<10 ,M) of unsaturated fatty acids enhance
lymphocyte growth and function (4-8). The mechanisms by
which fatty acids alter lymphocyte function are not fully
understood. Polyunsaturated fatty acids are converted to
various icosanoids having potent immunopharmacological
properties (9, 10). By contrast saturated and monounsat-
urated fatty acids have been proposed to act by changing the
organization or physical properties of immune cell mem-
branes, although this remains controversial (3, 10, 11).
In studies carried out in vivo (3, 12, 13) and in vitro (8, 14),
fatty acids have been shown to have a greater effect on T cells
and cell-mediated immunity than on B cells and humoral
immunity. For example, using highly purified murine T and
B lymphocytes, we showed that stearic acid potently inhib-
ited T-cell proliferation but had much less effect on B-cell
proliferation (8). At the same concentration (50AM), oleic
acid was without effect; however, when added simultane-
ously with stearic acid, oleic acid could obviate the inhibitory
effects of the saturated fatty acid (8, 15). Subsequent studies
regarding the effects of free fatty acids on in vitro primary
antibody responses provided results consistent with our
earlier findings where stearic acid was shown to inhibit
thymus-dependent but not thymus-independent antibody re-
sponses (14). More recently we have obtained additional
evidence implicating T helper cells as the target for saturated
fatty acid inhibition in primary antibody responses (S. Pour-
bohloul and T.M.B., unpublished observations).
The differential effect of saturated fatty acids on T and B
cells suggests that the two lymphocyte types differ either in
fatty acid uptake and utilization or in their abilities to tolerate
changes in membrane fatty acid composition. To address this
question, we have compared purified B and T lymphocytes
for their abilities to incorporate and metabolize exogenous
stearic acid. Because the initial results of this work indicated
that T cells were unable to desaturate stearic acid to yield
oleic acid, subsequent studies were undertaken to compare B
and T cells for their levels of stearoyl-CoA desaturase
(acyl-CoA, hydrogen-donor:oxygen oxidoreductase, EC
1.14.99.5). The results reported here demonstrate a funda-
mental difference in lipid metabolism between B and T
lymphocytes.
MATERIALS AND METHODS
Lymphocyte Isolation and Culture. Purified T and B lym-
phocytes were isolated from spleens of 8- to 12-week-old
BALB/c mice (Charles River Breeding Laboratories) as
described (16). As demonstrated by immunofluorescence
studies, the recovered B- and T-cell populations were typi-
cally >97% positive for surface immunoglobulin or Thy 1.2,
respectively (16). Lymphocytes were cultured and assayed
for proliferation as described (16).
Assay of Fatty Acid Uptake. [1-14C]Stearic acid (59 mCi/
mmol; 1 Ci = 37 GBq; New England Nuclear) was complexed
to bovine serum albumin before its addition to culture (8).
Fatty acid uptake was assayed with 3 x 106 cells. After
extraction of cellular lipids with chloroform/methanol (17),
aliquots were removed to measure total ['4C]stearic acid
uptake.
Lipid Analyses. Lymphocyte lipids were separated into
phospholipids and neutral lipids by TLC on silica gel 60 plates
(Merck) developed with petroleum ether/diethyl ether/
acetic acid (75:25:1) or chloroform/methanol/acetic acid/
H20 (75:45:12:5.5). Fatty acid methyl esters were separated
by reversed-phase and argentation TLC (18). Radiolabeled
lipids were quantified using a RITA linear radioactivity
detector (Raytest, Muenster, F.R.G.).
For analysis of molecular species, radiolabeled phosphati-
dylcholine fractions were converted to diacylglycerides by
phospholipase C digestion (19) followed by benzylation (20,
21). The benzylated (20) or dinitrobenzylated (21) diacylglyc-
erides were separated with a Beckman model 332R HPLC
fitted with a 4.6 x 45 mm precolumn and a Beckman 4.6 x
250 mm analytical column, both packed with 5-gm C18
Ultrasphere. Molecular species were separated by isocratic
elution with acetonitrile/2-propanol (80:20; vol/vol) and a
column flow rate of 1 ml/min. Separated molecular species
were detected and quantified by monitoring their UV adsorp-
tion at 230 nm. Radiolabeled diacylglycerobenzoates were
Abbreviations: LPS, lipopolysaccharide; PHA, phytohemagglutinin.
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quantitated by collection of 1-ml fractions, which were dried
before liquid scintillation counting. Molecular species were
identified by comparing their retention volumes to those of
known authentic standards, as well as by gas/liquid chro-
matography analysis (22) of the fatty acyl methyl esters
obtained following transesterification [5% (vol/vol) HCl/
methanol for 2 hr at 750C] ofthe recovered molecular species.
Isolation and Assay of Stearoyl-CoA Desaturase Activity.
Approximately 1 x 108 B orT lymphocytes were washed with
phosphate-buffered saline (pH 7.2) and resuspended in 10
mM Tris buffer (pH 7.6) containing 0.5 mM MgCl2 and
phenylmethanesulfonyl fluoride at 150 Mug/ml. The cell sus-
pension was sonicated for 5 sec by using a Biosonik III
sonicator (Bronwill) set at maximum output. After centrifu-
gation of the suspension (10 min at 2000 x g, 40C), the
recovered membrane pellet was resuspended in the Tris
buffer, and protein was measured by a modified Lowry
procedure (23).
Stearoyl-CoA desaturase activity was measured by assay-
ing the conversion of [1-14C]stearoyl-CoA to [1-14C]oleic acid
(24). Equivalent amounts of T- and B-cell membrane protein
were added to an assay mixture containing 0.1 M Tris (pH
7.2), 1 mM NADH, and 70 uM [1-'4C]stearoyl-CoA (New
England Nuclear; 5.5 mCi/mmol), and the mixture was
incubated for 20 min at 37°C. The reaction was stopped with
10%6 (wt/vol) KOH/methanol (80°C for 30 min). After acid-
ification, fatty acids were recovered and converted to methyl
esters for analysis by argentation TLC.
Northern (RNA) Analyses of T and B Cells. Cellular RNA
was isolated from =1 x 108 B or T cells after washing them
twice with Ca2l- and Mg2"-free phosphate-buffered saline.
The cell pellet was lysed in guanidinium isothiocyanate (25)
and loaded onto a cushion of 5.7 M CsCl containing 100 mM
EDTA. The RNA was collected by ultracentrifugation at
30,000 x g for 48 hr. After ethanol precipitation, the RNA
pellet was resuspended in Tris/EDTA buffer (10 mM Tris,
pH 7.6/1 mM EDTA). Poly(A)+ RNA was isolated, the
concentration was determined by UV spectrophotometry,
and 2-5 ,ug of poly(A)+ RNA was denatured with formalde-
hyde/formamide and electrophoresed in 1.2% agarose gels
containing formaldehyde as described (26). Blotting of RNA
gels was performed by standard procedures (26). The size of
mRNA transcripts encoding stearoyl-CoA desaturase and
,8-actin were determined by linear regression analysis, with
use of an ethidium bromide-stained 0.24- to 9.5-kilobase (kb)
RNA ladder (BRL).
A cDNA probe for stearoyl-CoA desaturase was provided
by Philipp Strittmatter (University of Connecticut, Farming-
ton) (27), and a chicken f-actin probe was purchased from
Oncor (Gaithersburg, MD). The probes were labeled by
random priming (28) with [a-32P]dCTP (New England Nu-
clear; 3000 Ci/mmol). Prehybridization was performed for 4
hr at 42°C in a solution consisting of 50% deionized form-
amide, 4x SSC (1x SSC = 0.15 M sodium chloride/0.015 M
sodium citrate), 5x Denhardt's solution (lx Denhardt's
solution = 0.02% polyvinylpyrrolidone/0.02% Ficoll/0.02%
bovine serum albumin), denatured salmon sperm DNA at 25
,g/ml, 0.05 M sodium phosphate buffer (pH 7), sodium
pyrophosphate at 0.5 mg/ml, and 1% SDS. Hybridization
was performed in the same solution except that the Den-
hardt's solution was 1x, and -2.5 x 107 cpm of denatured
probe was added. Hybridizatipn was allowed to occur for
16-20 hr at 42°C. After hybridization, the filters were washed
(final wash was at 65°C in 0.1 x SSC/0.1% SDS), wrapped in
plastic wrap, and put in a DuPont Cronex cassette with
Lightning Plus intensifying screens for 1-3 days at -70°C.
Intensities of hybridization were determined by scanning
autoradiographs with a Zeineh soft laser densitometer
(Biomed Instruments, Fullerton, CA).
Statistical Analyses. Differences in lipid composition be-
tween unstimulated versus stimulated lymphocytes or be-
tween stearic acid-treated and -untreated lymphocytes were
tested for significance (P < 0.05) by two-tailed, paired
Student's t tests.
RESULTS
Incorporation of [1-'4C]Stearic Acid into B- and T-Cell
Lipids. Time-course studies of [1-14C]stearic acid uptake by
T and B lymphocytes were initially carried out to determine
whether activated T cells incorporated more stearic acid than
either activated B cells or resting (unstimulated) T or B cells.
Purified T and B lymphocytes were incubated in the presence
of 45 MtM [1-14C]stearic acid and either stimulated with
phytohemagglutinin (PHA) or lipopolysaccharide (LPS), re-
spectively, or left unstimulated. Selection of this fatty acid
dose was based on our previous studies showing that 45 "M
stearic acid inhibited T-cell proliferation by >90%, while
having much less effect on B-cell proliferation (8). At various
times, aliquots were removed from the cultures, and the
amounts of [1-14C]stearic acid incorporated into T- and B-cell
phospholipids and neutral lipids were determined. Fig. 1
shows that resting B and T cells incorporated similar amounts
of [1-14Clstearic acid into the various phospholipids and
neutral lipids. In both lymphocyte types, phosphatidylcho-
line was the major (60-65%) phospholipid labeled, whereas
fatty acids were the major (60-65%) neutral lipid species
labeled. The nearly identical incorporation of [1-14C]stearic
acid into the resting T- and B-cell lipids is consistent with our
previous finding that stearic acid is not toxic for unstimulated
lymphocytes of either type (22).
In LPS-activated B cells and PHA-activated T cells, [1-
14C]stearic acid incorporation into each of the phospholipids
and neutral lipids (except fatty acids) was increased within
6-8 hr after mitogen addition (Fig. 1). The activated T cells
incorporated 1.5- to 2-fold more fatty acid than activated B
cells. However, based on [3H]thymidine uptake measure-
ments (=95,000 cpm for untreated, LPS-activated B cells;
-150,000 cpm for untreated, PHA-activated T cells), the
difference in fatty acid uptake probably reflects the propor-
tions of B or T cells activated by the two mitogens. Thus, the
selective toxicity of stearic acid towards T cells could not be
correlated with differences in fatty acid uptake by the two
lymphocyte types.
Changes in Phospholipid Molecular Species in Stearic Acid-
Treated B and T Cells. Although B and T lymphocytes
incorporated nearly identical amounts of [1-14C]stearic acid
into the various cellular lipids, preliminary studies suggested
that B and T cells incorporated the fatty acid into distinct
phospholipid molecular species. Therefore, mitogen-
stimulated B and T lymphocytes were recovered after over-
night (16-hr) incubation in the absence or presence of 50 ,uM
stearic acid, and their phosphatidylcholine molecular species
were quantified. Mitogen-activated T and B cells incubated
for 16 hr without stearic acid contained 16 different phos-
phatidylcholine molecular species, with palmitic acid/oleic
acid and stearic acid/linoleic acid (in a ratio of 3:1) being the
predominant species (Fig. 2A). Overnight supplementation of
T cells with 50 MuM stearic acid resulted in a significant (P <
0.0001) decrease in palmitic acid/oleic acid, with concomi-
tant increases in stearic acid/oleic acid (P < 0.005) and
distearoylphosphatidylcholine (P < 0.02) (Fig. 2B). B cells
incubated with 50 MuM stearic acid (Fig. 2C) also displayed a
decrease in palmitic acid/oleic acid (P < 0.003) and a
corresponding increase in stearic acid/oleic acid (P < 0.02),
but the small increase of distearoylphosphatidylcholine ob-
served was not significant (P = 0.13). Thus, after a 16-hr
incubation in the presence of 50MM stearic acid, roughly 30%o
of T-cell phosphatidylcholine was in the distearoyl form,
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FIG. 1. Total uptake and incorporation of [1-14C]stearic acid([14C]-18:0) into T- and B-cell phospholipids and neutral lipids.
Purified T and B cells were incubated in the presence of 45 .AM[1-'4C]stearic acid and stimulated with either PHA or LPS, respec-
tively (e) or left unstimulated (o). At the times indicated, cellular
lipids were extracted and separated by TLC. PC, phosphatidylcho-
line; PE, phosphatidylethanolamine; PS + PI, phosphatidylserine
and phosphatidylinositol; FFA, free fatty acids; DAG, diacylglyc-
erides; and TAG, triacylglycerides. Data are the mean (±SEM) of
three to five separate experiments.
whereas this same species accounted for <8% of the total
phosphatidylcholine molecular species of B cells.
Desaturation of Exogenously Derived Stearic Acid by B and
T Cells. To determine the basis for the greater accumulation
of distearoylphosphatidylcholine in T cells, T and B lympho-
cytes were compared subsequently for possible differences in
their abilities to desaturate exogenously derived [1-
14C]stearic acid to yield [1-14C]oleic acid. The two cell types
were incubated in the presence of three concentrations of[1-'4C]stearic acid and either stimulated with mitogen or left
unstimulated. After 7 hr, total T- and B-cell phospholipids
were recovered and analyzed for their contents of radiola-
beled fatty acids. Fig. 3 shows that phospholipids from B cells
incubated in the presence of [1-14C]stearic acid contained
both [1-14C]stearic acid and [1-'4C]oleic acid. Over the con-
centration range of exogenous [1-14C]stearic acid provided,
the proportion of [1-'4C]oleic acid ranged from 12% of total
radiolabeled phospholipid fatty acids in cells exposed to 40
,uM [1-_4C]stearic acid to 23% in cells treated with 160 utM[1-_4C]stearic acid. By contrast, T cells contained much lower
amounts of [1-14C]oleic acid, most notably in T cells incu-
bated at the higher doses of [1-14C]stearic acid tested,
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FIG. 2. Effect of stearic acid supplementation on the phosphati-
dylcholine molecular species ofT and B lymphocytes. Purified T and
B cells were left unstimulated (A) or were stimulated with PHA (T
cells; B) or LPS (B cells; C), with or without 50AM stearic acid. After
16 hr the cells were harvested and analyzed for their phosphatidyl-
choline molecular species. No differences were detected between
untreated T and B cells; therefore, the data from the individual
lymphocyte types were combined to yield the data ofA for control
T and B cells. Data are shown only for the major molecular species
and represent the mean (+SEM) of three separate experiments.
Asterisks denote molecular species significantly different from con-
trol cells: *, P < 0.02; **, P < 0.005; ***, P < 0.0001. Molecular
species: 1, oleic acid/arachidonic acid; 2, palmitic acid/linoleic acid;
3, dioleoyl acid; 4, palmitic acid/oleic acid and stearic acid/linoleic
acid; 5, stearic acid/oleic acid; 6, distearoyl acid.
wherein radiolabeled unsaturated fatty acids accounted for
only 1-2% of total radiolabeled phospholipid fatty acids. The
data in Fig. 3 also show that this difference was seen between
resting as well as mitogen-stimulated T and B cells. Addi-
tional studies involving longer incubation times (13, 16, and
21 hr) yielded similar results (data not shown).
Stearoyl-CoA Desaturase Activity in B and T Cells. To
confirm the apparent absence of oleic acid synthesis in T
cells, cell-free extracts were prepared from unstimulated as
well as mitogen-stimulated B and T cells and assayed for
stearoyl-CoA desaturase activity. Cell-free extracts prepared
from unstimulated and LPS-activated B cells displayed >20
times more stearoyl-CoA desaturase activity than did ex-
tracts prepared from either unstimulated or Con A-stimulated
T cells (Table 1). Similar data were obtained with PHA-
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FIG. 3. Conversion of [1-14C]stearic acid (18:0) to [1-14C]oleic
acid by T and B cells. Purified T and B cells were either mitogen-
stimulated (A) or left unstimulated (B) and cultured with various
concentrations of [1-14C]stearic acid. After 7 hr cellular phospholip-
ids were recovered and analyzed for their contents of radiolabeled
fatty acids. Data are expressed as pmol of [1-14C]oleic acid ([1-
14C]18:1) recovered from the total phospholipids of 107 B cells (o) or
T cells (e).
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Table 1. Stearoyl-CoA desaturase activity in B and
T lymphocytes
Desaturase
[3H]Thymidine activity,
uptake, pmol of labeled
Cell cpm per Protein, 18:1 per mg
population 5 x 105 cells pug per 20 min
Experiment 1
B cells 1,234 ± 533 317 755
T cells 154 ± 25 317 0
B cells + LPS 39,462 ± 6746 343 726
T cells + Con A 64,497 ± 2792 343 48
Experiment 2
B cells + LPS 39,466 ± 1212 283 919
T cells + Con A 64,460 ± 5981 283 0
18:1, oleic acid.
stimulated T cells (data not shown). These results are con-
sistent with the data obtained with intact cells and demon-
strate a near total absence of stearoyl-CoA desaturase activ-
ity in resting and activated T lymphocytes.
Levels of Stearoyl-CoA Desaturase mRNA in B and T Cells.
Poly(A)+ RNA isolated from unstimulated and mitogen-
activated B and T cells was subjected to Northern (RNA)
analyses by using acDNA probe for stearoyl-CoA desaturase
(27). Fig. 4 shows that the desaturase cDNA probe hybrid-
ized to a single mRNA species with the expected size of =5
kb (29, 30). Fig. 4 also shows that desaturase mRNA was
present in both resting and LPS-stimulated B cells, but was
virtually absent from resting and Con A-stimulated T cells.
By comparison with f3-actin mRNA, which was expressed
equally in B and T cells, resting and stimulated B cells
contained >30 times more stearoyl-CoA desaturase mRNA
than resting or activated T cells. These data are consistent
with the demonstrated inability ofT cells to desaturate stearic
acid.
DISCUSSION
The results described in this study provide evidence that
murine T cells are deficient in unsaturated fatty acid synthe-
sis. The ability of lymphocytes to incorporate and use exog-
enously derived free fatty acids has been reported by numer-
ous workers, as has enhanced fatty acid uptake after mitogen
activation (5, 31-33). However, the previous studies involved
unfractionated lymphocyte populations containing both B
B T
- t - + kb
Desaturase 5
/3-Actin 00W 2.1
FIG. 4. Northern blot analysis of resting and activated B and T
cells. One to 5 ,tg of poly(A)+ RNA from unstimulated (-) or
LPS-stimulated (+) B cells and unstimulated (-) or Con A-
stimulated (+) T cells was separated on formaldehyde-agarose gels,
transferred to nitrocellulose, and sequentially hybridized to 32P-
labeled cDNA probes for rat liver stearoyl-CoA desaturase and
chicken 83-actin.
and T cells, and it was not determined whether the fatty acids
were metabolized subsequent to their incorporation. By
making use of highly enriched B- and T-cell populations and
assaying the products of the exogenously derived stearic
acid, we have demonstrated that T and B cells differ in their
abilities to synthesize oleic acid. Whereas B cells converted
as much as 23% of the incorporated stearic acid to oleic acid,
T cells desaturated only 1-2%. A lack of desaturase activity
in T cells was similarly indicated by assaying stearoyl-CoA
desaturase activity in cell-free extracts prepared from B and
T lymphocytes. Membrane preparations isolated from both
resting and mitogen-activated B cells displayed >20-fold
more desaturase activity than membranes isolated from rest-
ing or activated T cells.
Northern analysis of stearoyl-CoA desaturase mRNA
yielded results that were also consistent with the apparent
absence of stearoyl-CoA desaturase activity in T cells. While
mRNA transcripts encoding the stearoyl-CoA desaturase
were detected in both resting and activated B cells, these
transcripts were virtually absent from resting or mitogen-
activated T cells. Thus, in both lymphocyte types the levels
of stearoyl-CoA desaturase mRNA coincided with amount of
desaturase activity obtained in cell-free extracts. Expression
of stearoyl-CoA desaturase in B and T cells is, therefore,
regulated at the level of transcription. Similar results have
been seen in rat and mouse liver (29, 34).
The inability of T cells to convert stearic acid to oleic acid
may be responsible for the toxic effects of saturated fatty
acids toward these cells. After an overnight incubation in the
presence of 50 tkM stearic acid, activated T cells contained
4-5 times more of the fatty acid in distearoylphosphatidyl-
choline than did activated B cells. Previous studies by Van
Deenen and coworkers have shown that stoichiometric re-
placement of erythrocyte phosphatidylcholine with distear-
oylphosphatidylcholine resulted in hemolysis when 22% of
native phosphatidylcholine had been exchanged (35, 36). This
level is equivalent to the amount of distearoylphosphatidyl-
choline observed in the stearic acid-treated T cells. If the
accumulation of distearoylphosphatidylcholine is, in fact,
responsible for the toxicity of stearic acid to T cells, then the
ability of B cells to avoid the synthesis of the toxic lipid
species may stem from their ability to desaturate stearic acid
to yield oleic acid. We have previously reported that the
simultaneous addition of oleic acid obviates the otherwise
toxic effects of the stearic acid (15), and we have recently
found that T cells supplemented with both stearic and oleic
acids do not accumulate distearoylphosphatidylcholine
(T.M.B., unpublished observations).
The finding that murine T cells do not synthesize olefinic
fatty acids is surprising but, nevertheless, agrees with reports
that T cells require exogenous unsaturated fatty acids for
growth in vitro. Several studies have shown that the addition
of either albumin-associated unsaturated fatty acids (4, 6) or
complex lipids containing olefinic acyl chains (37-39) to
serum-free culture medium significantly improved human
and murine lymphocyte proliferation in vitro. Indeed, unsat-
urated fatty acids may even be essential for PHA-induced
proliferation of human T cells cultured in serum-free medium
(4, 37). Thus, the demonstrated inability of T cells to syn-
thesize unsaturated fatty acids is consistent with the previous
studies.
Changes in the levels of dietary fat can profoundly alter
immune responses in vivo, and it has been suggested that T
cells are the predominant sensitive immune cell population
(3). Whether T lymphocytes are also dependent upon exog-
enous unsaturated fatty acids for proliferation and function in
vivo is not known. If T cells are so dependent, the ability of
B cells to synthesize monounsaturated fatty acids may enable
them to "fine-tune" the lipid composition of B cells, thereby
preserving permissive membrane properties.
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